
Supported by


The 2026 SNO Education Day, taking place on Thursday, November 12, 2026, gathers international thought leaders to highlight advances in "Bringing Science to the Clinical Forefront in Brain Tumor Treatment." Sessions will feature emerging diagnostics, AI and machine learning applications, biomarkers, targeted therapies, cell-based immunotherapies, and novel CNS drug delivery platforms—with a focus on honest introspection, challenges and obstacles to progress, and collective discussion on steps forward. Through multidisciplinary discussions spanning basic, translational, and clinical research, the program will focus on accelerating the translation of scientific discoveries into clinical applications and advancing care for patients with central nervous system tumors.

Wenya Linda Bi, MD, PhD

Jian Campian, MD, PhD

Praveen Raju, MD, PhD

Jeremy Rich, MD, MHS, MBA

David A. Solomon, MD, PhD

Bobby Mukkamala
President of The American Medical Association
Physician Leadership in Advocating for a Healthier Tomorrow
Thursday, November 12, 2026
8:40-9:10 AM | Education Day
For more information, click here.
Gerald Linette
University of Pennsylvania
Cancer Immunotherapy: The Emerging Landscape of TCR-T cell Therapies
Thursday, November 12, 2026
9:10-9:40 AM | Education Day
For more information, click here.
